# Diane M. Simeone

Source: https://onco.cc/people/diane-simeone/  
OnCo record `diane-simeone` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Pancreatic cancer surgeon-scientist who directs UC San Diego Moores Cancer Center, an NCI-designated comprehensive cancer center.

## Summary

Diane M. Simeone, MD, is Director of UC San Diego Moores Cancer Center and Professor of Surgery and Pharmacology. She is a surgical oncologist and pancreatic cancer researcher whose work spans pancreatic cancer stem cells, early detection in high-risk individuals and the Precision Promise adaptive platform trial. She previously directed the Pancreatic Cancer Center at NYU Langone.

## Fields

- Kind: Person
- Last checked: 2026-09-10
- Tags: leadership; clinician-scientist; pancreatic cancer; surgical oncology
- Role: Director, Moores Cancer Center; Koman Family Presidential Director's Chair
- Specialisms: Pancreatic cancer; Surgical oncology; Cancer early detection

## Sources

- Institution profile: https://moorescancercenter.ucsd.edu/about/leadership/
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Simeone+DM%5BAuthor%5D

## Connected records

- cancers: [BRCA or PALB2-mutant pancreatic ductal adenocarcinoma](https://onco.cc/cancers/brca-palb2-pdac/), [Intraductal papillary mucinous neoplasm and other pancreatic cystic precursors](https://onco.cc/cancers/ipmn-cystic-precursors/), [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/)
- institutions: [UC San Diego Moores Cancer Center](https://onco.cc/institutions/ucsd-moores/)
- journals: [International journal of cancer](https://onco.cc/journals/international-journal-of-cancer/)
- key papers: [Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium](https://onco.cc/key-papers/paper-caps-consortium-surveillance-recommendations-gut-2020/), [Pancreatic cancer early detection biomarkers for high-risk individuals: insights from the PRECEDE consortium](https://onco.cc/key-papers/paper-worthington-precede-early-detection-biomarkers-ijc-2026/), [Recommendations for a more organized and effective approach to the early detection of pancreatic cancer from the PRECEDE (Pancreatic Cancer Early Detection) consortium](https://onco.cc/key-papers/paper-gonda-precede-consortium-recommendations-gastroenterology-2021/)
- roadmaps: [Pancreatic cancer roadmap: from Whipple's operation to gemcitabine, FOLFIRINOX, adjuvant chemotherapy, PARP inhibition, KRAS inhibition, vaccines and the surveillance question](https://onco.cc/roadmaps/pancreatic-roadmap/)

---
JSON: https://onco.cc/api/v1/entities/diane-simeone.json